Mandate

Vinge advises O2 in connection with its application for listing on NASDAQ OMX Stockholm

March 09, 2010

Vinge is advising the wind power company OM Vind AB in connection with the company’s application for listing on NASDAQ OMX Stockholm. The expected first day of trading is 22 March 2010. A new issue of not less than MSEK 950 and not more than MSEK 1,150 will be performed in conjunction with the listing. SEB Enskilda and Swedbank Markets are Joint Lead Managers and Book Runners in the offering. Vinge is also advising on the restructuring of O2’s legal structure which will take place prior to O2’s shares being admitted to trading. Vinge has also advised O2 in connection with negotiation of loan agreements in the amount of approximately SEK 2.4 billion with a Nordic bank consortium consisting of DnB Nor, SEB and Swedbank.

Vinge’s team primarily consists of Lena Almefelt, Petter Alberts, Fredrik Stjernström, Helena Backlund, Christian Johansson, Johan Cederblad, Kimmie Johansson and Andreas Wirén. As regards the loan financing aspect of the transaction, Vinge’s team primarily consists of Mikael Ståhl, Christian Johansson and Ulrica Åkesson.

Related

Vinge advises Intera Partners’ portfolio company Yellow Elk in connection with its acquisition of Bizware

Vinge has advised the Nordic private equity firm Intera Partners’ portfolio company Yellow Elk in connection with its acquisition of the data analytics and AI firm Bizware AB and its subsidiaries Bizware Lead AB and Bizware Nova AB.
September 11, 2025

Vinge has acted as local counsel supporting lead counsel Latham & Watkins in advising Cadence in connection with its acquisition of Hexagon’s Design & Engineering Business for approx. EUR 2.7 billion

Cadence (Nasdaq: CDNS) announced it has entered into a definitive agreement to acquire the Design & Engineering business of Hexagon AB, which includes its MSC Software business—a pioneer in engineering simulation and analysis solutions.
September 09, 2025

Vinge has advised Oncopeptides in connection with its rights issue

Vinge has advised Oncopeptides AB (publ) in connection with a fully guaranteed rights issue which will provide Oncopeptides with proceeds of approximately SEK 150 million before deduction of transaction costs.
August 28, 2025